BIND Therapeutics Employee Directory
Biotechnology ResearchMassachusetts, United States2-10 Employees
BIND Therapeutics is a biotechnology company founded in 2006 and based in Cambridge, Massachusetts. Its work centers on developing targeted drug delivery systems designed to direct therapeutic agents to specific cells and tissues involved in disease, aiming to enable treatment approaches not achievable with conventional methods. The company’s primary focus has been on ACCURINS, proprietary nanoparticles intended to enhance targeting and therapeutic outcomes, with ongoing development activity in collaboration with Pfizer. The market for BIND’s work lies in oncology and other areas where precise delivery can improve treatment effectiveness. Its location in the Cambridge biopharma ecosystem places it among a concentration of research-focused firms pursuing advanced delivery technologies. Recent developments include collaborations with Pfizer related to the continued development of ACCURINS, reflecting ongoing partnerships within the pharmaceutical industry.